5.690USD-7.48%Mkt Cap: 85.10M USDP/E: —Last update: 2026-06-01
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment o…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap85.10M USD
Enterprise Value90.88M USD
Revenue (TTM)41.94M USD
Gross Profit37.85M USD
Net Income (TTM)-2.84M USD
Revenue/Share2.823 USD
Last Price5.690 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees93
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)43.93
PEG1.67
EV/EBITDA-32.19
EV/Revenue2.17
P/S2.20
P/B4.26
EPS (TTM)-0.49
EPS (Forward)0.14
52W Range
1.85081% of range6.610
52W High6.610 USD
52W Low1.850 USD
Profitability
Gross Margin85.02%
Oper. Margin-34.27%
EBITDA Margin-6.73%
Profit Margin-6.37%
ROE-11.40%
ROA-3.69%
Growth
Revenue Growth-22.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.93M USD
CapEx (TTM)182.31K USD
FCF Margin11.70%
FCF Yield5.77%
Net Debt-937.46K USD
Net Debt/EBITDA0.33
Balance Sheet
Debt/Equity0.41
Current Ratio0.95
Quick Ratio0.73
Book Value/Sh1.444 USD
Cash/Share0.7350 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.98M
Float8.75M
Insiders41.60%
Institutions18.49%
Short Interest
Short Ratio0.2d
Short % Float5.19%
Short % Out.3.04%
Shares Short454.75K
Short (prev mo.)112.90K
Technical
SMA 503.971 (+43.3%)
SMA 2003.534 (+61.0%)
Beta-0.06
S&P 52W Chg27.94%
Avg Vol (30d)1.97M
Avg Vol (10d)189.40K
Technical Indicators
RSI (14)75.3
MACD0.5648
MACD Signal0.5045
MACD Hist.+0.0603
BB Upper6.368 USD
BB Middle5.119 USD
BB Lower3.870 USD
BB Width48.80%
ATR (14)0.4033 USD
Vol Ratio (20d)0.20x